Physician

Ali Nowroozi Esfahani, MD, MBA

According to 2025 Medicare claims, Ali Esfahani, MD, MBA (NPI: 1821529710) practices physical medicine and rehabilitation, with the plurality of this provider's patient population coming from Ross, OH. This provider's primary affiliated billing organization is ADENA MEDICAL GROUP LLC (NPI: 1235468083; TIN: 314379443) and primary practice location at 45601-9031. Esfahani is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Esfahani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 299 traditional Medicare patients, billed 775 HCPCS/CPT codes, and received $51,118 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,612 prescription claims across 282 beneficiaries totaling $25,221 in drug costs, led by Pregabalin (Pregabalin). Open Payments data shows 4 records totaling $136. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,614 to $25,221. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	54	67	$5,154
2022	192	415	$32,734
2023	210	620	$43,341
2024	299	775	$51,118

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	14	27	$1,614
2018	15	35	$4,197
2019	N/R	12	$746
2020	N/R	N/R	N/R
2021	N/R	18	$110
2022	51	99	$1,927
2023	202	847	$17,904
2024	282	1,612	$25,221

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	39	39	$127
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	88	88	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	180	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	115	179	$56
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	43	53	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pregabalin	Pregabalin	227	6,765	$4,969
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	134	3,444	$3,103
Gabapentin	Gabapentin	301	8,991	$2,910
Celecoxib	Celecoxib	67	2,118	$2,422
Lidocaine	Lidocaine	12	360	$1,567

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$136	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Nowroozi Esfahani, MD, MBA?

Tedicare shows public-source Medicare data for Ali Nowroozi Esfahani, MD, MBA (NPI 1821529710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Nowroozi Esfahani, MD, MBA have ACO affiliation data?

Ali Nowroozi Esfahani, MD, MBA is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ali Nowroozi Esfahani, MD, MBA?

Ali Nowroozi Esfahani, MD, MBA is linked to ADENA MEDICAL GROUP LLC (billing NPI 1235468083) in the available physician profile data.

Does Ali Nowroozi Esfahani, MD, MBA have Open Payments data?

Ali Nowroozi Esfahani, MD, MBA has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.